Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 78 publications
IL-1β/IL-6 signaling circuit in the tumor microenvironment drives prostate cancer development.
Journal: bioRxiv : the preprint server for biology
Published: August 20, 2026
Author Correction: Zbtb7a suppresses prostate cancer through repression of a Sox9-dependent pathway for cellular senescence bypass and tumor invasion.
Journal: Nature genetics
Published: February 09, 2026
Toward an Emerging Public Health Paradigm: Agriculture and Food Production for Health.
Journal: Foods (Basel, Switzerland)
Published: October 30, 2025
Targeting Tumor Microenvironment-Derived NRG1-HER2/3 Signaling with Zenocutuzumab Restores Sensitivity to AR Inhibition in PTEN Wild-type Prostate Cancer.
Journal: Molecular cancer therapeutics
Published: May 05, 2025
Erratum: Paclitaxel, Ifosfamide, and Cisplatin as Initial Salvage Chemotherapy for Germ Cell Tumors: Long-Term Follow-Up and Outcomes for Favorable- and Unfavorable-Risk Disease.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: March 14, 2025
Uncoupling of Akt and mTOR signaling drives resistance to Akt inhibition in PTEN loss prostate cancers.
Journal: Science advances
Published: February 07, 2025
Oncologic outcomes of retroperitoneal lymph node dissection following first-line chemotherapy for metastatic non-seminomatous germ-cell tumors.
Journal: Annals of oncology : official journal of the European Society for Medical Oncology
Published: September 03, 2024
Long-term Clinical Outcomes of Patients With Negative Pathology (pN0) at Primary Retroperitoneal Lymph Node Dissection.
Journal: Clinical genitourinary cancer
Published: August 02, 2024
Paclitaxel, Ifosfamide, and Cisplatin as Initial Salvage Chemotherapy for Germ Cell Tumors: Long-Term Follow-Up and Outcomes for Favorable- and Unfavorable-Risk Disease.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: July 19, 2024
Pelvic Lymph Node Dissection in Prostate Cancer: Update from a Randomized Clinical Trial of Limited Versus Extended Dissection.
Journal: European urology
Published: June 26, 2024
ERG-driven prostate cancer initiation is cell-context dependent and requires KMT2A and DOT1L.
Journal: Nature genetics
Published: June 14, 2024
Last Updated: 09/26/2026